Transcatheter aortic valve replacement was associated with improved survival in high-risk patients with diabetes and aortic stenosis, according to new research. Mortality at one year was 18% in patients treated with TAVR, compared with 27.4% in those who had surgical aortic valve replacement. The results were presented at the European Society of Cardiology Congress.
Study: TAVR lowers mortality in high-risk diabetes patients
SmartBrief Job Listings for Health Care
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||